AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia

Clinical trial NCT00474240 · COMPLETED

Trial details

NCT number: NCT00474240
Sponsor: Aegerion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2007-04-01
Primary completion: 2008-10-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.